GC69164
Glenzocimab
Glenzocimab (ACT017) is a humanized monoclonal antibody Fab fragment that targets GPVI· Glenzocimab inhibits collagen-induced platelet aggregation and has potential in the research of acute ischemic stroke
ChemicalCAS2101829-58-5
- CAS number
- 2101829-58-5
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC69164
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il